期刊文献+

同型半胱氨酸与白细胞介素6、膜相关前列腺素E合成酶的关系

Relationship between homocysteine and the expression of IL 6 and mPGEs in human peripheral blood mononuclear cells
原文传递
导出
摘要 目的探讨同型半胱氨酸(HCY)和过氧化物酶增殖物激活受体(PPAR)γ与白细胞介素(IL)6和膜相关前列腺素E合成酶(mPGEs)蛋白表达之间的关系。方法抽取正常志愿者静脉血分离外周血单个核细胞(PBMC)并培养,分别加入不同浓度的HCY及PPAR-γ激活剂培养24h,收集细胞培养液上清,采用ELISA测定IL-6、mPGEs的水平。结果HCY实验组IL-6、mPGEs水平高于对照组(P<0.01或P<0.05),IL-6和mPGEs水平随HCY剂量升高而升高,呈剂量依赖性(P<0.01或P<0.05)。PPAR-γ激活剂对100μmol/LHCY引起IL-6和mPGEs水平的升高有明显抑制作用(P<0.05或P<0.01)。结论HCY促进PBMCIL-6及mPGEs蛋白表达增加;PPAR-γ激活剂对HCY引起IL-6和mPGEs水平升高有抑制作用。 Objective To investigate the relationship of homocystein (HCY) with IL 6 and membrane associated prostaglandin E synthase(mPGEs)expression in human peripheral blood mononuclear cells and observe the effect of peroxisome proliferator activated receptors(PPAR γ) activator(troglitazone and rosiglitazone)on above relationship. Methods Human peripheral blood mononuclear cells(PBMC) were isolated from healthy volunteers, then cultured and intervened with HCY,troglitazone and rosiglitazone for 24 hours.ELISA was used to examine IL 6 and mPGEs in the supernants of cell culture. Results The concentration of IL 6 and the A value of mPGEs in HCY experimental groups were higher than those in control (P< 0 01 or P< 0 05). The concentration of IL 6 and the A value of mPGEs increased in dose dependent manner from 20 μmol/L to 100 μmol/L of HCY. All groups of troglitazone and rosiglitazone significantly reduced the level of IL 6 and mPGEs induced by 100 μmol/L HCY (P< 0 05 or P< 0 01), but no significant differences among these groups were found. Conclusions HCY can stimulate PBMC to release IL 6 and to express mPGEs in dose dependent manner. PPAR γactivators can inhibit above stimulation.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2004年第1期42-46,共5页 Chinese Journal of Nephrology
基金 湖南省卫生厅重点项目资助(Z0206)
关键词 同型半胱氨酸 白细胞介素6 膜相关前列腺素E合成酶 过氧化物酶增殖物激活受体Γ 细胞培养 慢性肾功能不全 Homocysteine Interleukin 6 Prostaglandin E synthase Peroxisome proliferator activated receptors
  • 相关文献

参考文献2

二级参考文献11

  • 1Dennis VW, Robinson K. Homocysteinemia and vascular disease in end-stage renal disease[J]. Kidney Int Suppl, 1996, 57:S11-17.
  • 2Bethesda US. Department of health and human service, Public Health, National institutes of Health [ J ]. United States Renal Data System Report, 1998, 79.
  • 3Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation and athemsclerosis in chronic renal failure[J]. Kidney Int, 1999, 55: 1899-1911.
  • 4George A, Kaysen C. C-reactive protein: a story half told [ J ].Seminars in Dialysis, 2000, 13, 143-146.
  • 5Shemin D, Lapne KL, Bausserman L, et cd. Plasma totoal homocystelne and hemodialysis acess thrombosis: a prospective study[ J ]. J Am Soe Nephrol, 1999, 10: 1095-1099.
  • 6Chauveau P, Chadefaux B, Coude M, et al. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patiens[J]. Kidney Int Suppl, 1993, 43: S72-77.
  • 7Selhub J, Dangelo A. Relationship between homocysteine and thrombotic disease[J]. Am J Med Sci, 1998, 316: 129-141.
  • 8Pema AF, Ingrosso D, De Santo NG, et al. Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia[J]. J Am Soc Nephrol, 1997, 8: 1899-1905.
  • 9李群.全国高同型半胱氨酸血症与疾病学术研讨会纪要[J].中华医学杂志,1999,79(6):406-408. 被引量:81
  • 10张广森,戴崇文.缺血性心脑血管病患者血浆同型半胱氨酸水平及其代谢相关酶基因多态性分析[J].中华血液学杂志,2002,23(3):126-129. 被引量:65

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部